Food allergies

Aimmune’s PALISADE-ARC004 Longitudinal Study Showed PALFORZIA® Safety and Efficacy Increased Over Time in Patients with Peanut Allergy

Retrieved on: 
Wednesday, August 4, 2021
Biotechnology, Pharmaceutical, Health, Clinical Trials, Food allergies, Medical specialties, Arachis, Medicine, Food and drink, Peanut allergy, Peanut allergen powder, Peanut, Placebo-controlled study, Kari Nadeau, Palifermin, PALISADE-ARC004, Aimmune, Nestlé Health Science, PALISADE-ARC004, AIMMUNE, NESTLé HEALTH SCIENCE

The manuscript, titled Open-label follow-on study evaluating the efficacy, safety, and quality of life with extended daily oral immunotherapy in children with peanut allergy, was published online.

Key Points: 
  • The manuscript, titled Open-label follow-on study evaluating the efficacy, safety, and quality of life with extended daily oral immunotherapy in children with peanut allergy, was published online.
  • Patients who completed the PALISADE trial were eligible to enter the ARC004 open-label follow-on study, which evaluated the long-term efficacy and safety of daily PALFORZIA dosing beyond one year (52 weeks).
  • After two years of daily PALFORZIA treatment, 80.8% of study participants tolerated 2000 mg of peanut protein in the double-blind, placebo-controlled food challenge.
  • PALISADE (Peanut Allergy oral Immunotherapy Study of AR101 for Desensitization) was an international, randomized (3:1), double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy and safety of AR101 in patients with peanut allergy.

Nature's Sunshine Issues Allergy Alert On Undeclared Milk In Its "Love & Peas" Meal Replacement Shake

Retrieved on: 
Friday, July 30, 2021
Medical specialties, Food allergies, Food and drink, Milk, Clinical medicine, Dairy products, Milk allergy, Allergy

Customers with a milk allergy or severe sensitivity to milk may experience a serious allergic reaction if they consume the affected product.

Key Points: 
  • Customers with a milk allergy or severe sensitivity to milk may experience a serious allergic reaction if they consume the affected product.
  • Although Nature's Sunshine made every effort to individually notify affected consumers in April 2021, it is making this announcement out of an abundance of caution in case any affected product remains in commerce.
  • The affected product is from lot numbers 001220292; 001223066; 001222059; 001215380; 001222934; 001218022; 001223890; 001220084; and 001224031.
  • Customers may choose to dispose of the product and receive a full product credit or continue to consume the product.

Intrommune Therapeutics Presents at Next Generation Food Allergy Drug Summit

Retrieved on: 
Thursday, July 22, 2021
Medical specialties, Clinical medicine, Medicine, Food allergies, Immune system, Immunology, Allergology, Allergy, Allergen immunotherapy, Immunotherapy, Kari Nadeau, Allergies in dogs

NEW YORK, July 22, 2021 (GLOBE NEWSWIRE) -- Intrommune Therapeutics , a New York-based clinical stage biotechnology company developing a patient-friendly treatment platform for peanut and other food allergies, is participating in the Next Generation Food Allergy Drug Summit.

Key Points: 
  • NEW YORK, July 22, 2021 (GLOBE NEWSWIRE) -- Intrommune Therapeutics , a New York-based clinical stage biotechnology company developing a patient-friendly treatment platform for peanut and other food allergies, is participating in the Next Generation Food Allergy Drug Summit.
  • Dr. Reisacher is also the inventor of oral mucosal immunotherapy (OMIT) and is a Senior Scientific Advisor to Intrommune Therapeutics.
  • Success with allergy immunotherapy hinges on consistent exposure of a patients immune system to gradually desensitize the patient to the specific allergy trigger over time.
  • Intrommune , dedicated to improving and protecting the lives of people with food allergy, is developing the revolutionary oral mucosal immunotherapy (OMIT) treatment platform for food allergies.

Quirch Foods Issues a Market Withdrawal of Mambo Brand Frozen Pandebono

Retrieved on: 
Thursday, July 15, 2021
Food, Beverage, Supply chain management, Other Retail, Retail, Supermarket, Food, Beef, Food allergies

Quirch Foods announced today that it has ordered a voluntary market withdrawal of Mambo Brand Pandebono due to possible cross contamination of wheat in the processing facility.

Key Points: 
  • Quirch Foods announced today that it has ordered a voluntary market withdrawal of Mambo Brand Pandebono due to possible cross contamination of wheat in the processing facility.
  • The processing plant has taken the necessary allergen controls to prevent cross contamination, however, Quirch Foods deemed it necessary to remove the product from commerce.
  • Quirch is the exclusive distributor of High River Angus, McKinneys Beef, Panamei Seafood, Diamond Reef Seafood, Kikiriquirch poultry, Jackson Farms, Mambo Foods, and is a licensed distributor of Certified Angus Beef and Chiquita Brands frozen Tropicals and Fruits.
  • To learn more about Quirch Foods and our brands, visit us online , follow Quirch ( Facebook , Twitter , Instagram , LinkedIn ), or call (800) 458-5252.

Cell Science Systems Reports Newly Discovered Cause of Delayed Food Allergies (Sensitivities)

Retrieved on: 
Tuesday, July 13, 2021
Other Consumer, Medical devices, Infectious diseases, Women, Seniors, Genetics, Fitness & Nutrition, MEN, Other Technology, Clinical trials, Family, Biotechnology, Alternative medicine, Hardware, Consumer, Health, Science, Other Science, Technology, Research, Diabetes, Nanotechnology, Stem cells, Practice Management, Managed care, General Health, Teens, Parenting, Children, Other Health, Oncology, Medical specialties, Immunology, Clinical medicine, Food allergies, Allergology, Immune system, Respiratory diseases, Allergy, Immunoglobulin E, Wheat allergy, Allergies in cats

However, researchers from University Leipzig (Germany) and Georgetown University together with Cell Science Systems may have found the key to understanding the most difficult type of food allergies know as delayed food allergies or sensitivities.

Key Points: 
  • However, researchers from University Leipzig (Germany) and Georgetown University together with Cell Science Systems may have found the key to understanding the most difficult type of food allergies know as delayed food allergies or sensitivities.
  • Delayed food allergies or sensitivities (also referred to as non-IgE mediated food allergies) are difficult to identify because symptoms are less acute and may take hours or even days to develop.
  • Hence, there is a great need for a test that can accurately and cost-effectively identify food and food product triggers of delayed food allergies.
  • ), are responsible for delayed food allergies and release more DNA, and other associated proteins, when exposed to an ALCAT Test positive food.

Nabati Foods Plant Based Meat and Cheeze Products Launch in the U.S.

Retrieved on: 
Thursday, June 17, 2021
Diets, Food allergies, Food, Gluten-free diet, Gluten, Kashrut, Milk allergy, Nabati, Articles, Branches of biology, Nutrition

All Nabati products are kosher, vegan, egg-free, dairy-free, gluten-free, and made without GMOs or refined sugar.

Key Points: 
  • All Nabati products are kosher, vegan, egg-free, dairy-free, gluten-free, and made without GMOs or refined sugar.
  • Nabati Foods is excited to partner with a major health publication like VegNews, Yehya said.
  • Nabati Foods will look to capitalize on this momentum in the weeks and months ahead.
  • Subscribe to updates about Nabati here: https://invest.nabatifoods.com/
    Find Nabati products at a location near you here: https://www.nabati.ca/a/store-locator
    Nabati Foods Global Inc. is the owner of Nabati Foods Inc. (Nabati), a family-founded food tech company offering whole, natural, plant-based, gluten, and soy-free foods for health-conscious consumers.

New Life-Changing Test for Patients Diagnosed With Peanut Allergy

Retrieved on: 
Tuesday, June 15, 2021
Medical specialties, Immunology, Clinical medicine, Food allergies, Allergology, Immune system, Medical tests, Allergen, Peanut allergy, Tree nut allergy, Allergy, Oral food challenge

The findings are life-changing for food allergy patients who previously turned to a potentially risky and often anxiety-producing procedure called an oral food challenge (OFC) to rule out a food allergy.

Key Points: 
  • The findings are life-changing for food allergy patients who previously turned to a potentially risky and often anxiety-producing procedure called an oral food challenge (OFC) to rule out a food allergy.
  • A new, risk-free and non-invasive blood test is a major breakthrough for allergy patients, their families, caregivers and providers.
  • Years later we had an opportunity to try AllerGenis' peanut allergy test, which confirmed it was highly unlikely Isabelle still had a peanut allergy.
  • "The accuracy of this test brings us one step closer to eliminating the need to subject patients to an oral food challenge to diagnose peanut allergy."

Global Allergy Diagnostic and Treatment Market (2021 to 2029) - Featuring bioMerieux, Siemens Healthcare and Danaher Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, June 14, 2021
Health, Pharmaceutical, Medical specialties, Clinical medicine, Medicine, Allergy, Immune system, Immunology, Food allergies, ALK-Abelló

According to the World Allergy Organization (WAO) study, the prevalence of allergy ranges from 10% - 40% across all age groups of population.

Key Points: 
  • According to the World Allergy Organization (WAO) study, the prevalence of allergy ranges from 10% - 40% across all age groups of population.
  • Thus increase in prevalence of allergic diseases and novel diagnostic and treatment products entering the market are the key factors governing the growth of allergy diagnostics and treatment market.
  • What is the key impact of COVID-19 over market revenues and market determinants in the medical aesthetics market?
  • Who are the key players in the allergy diagnostics and treatment market and what are their key product categories and strategies?

Alerje Announces Granted Patent for an Epinephrine Auto-Injector for Smartphones that Supports Families with Severe Food Allergies.

Retrieved on: 
Thursday, June 3, 2021
Medical specialties, Clinical medicine, Immunology, Respiratory diseases, Food allergies, Allergology, Medical emergencies, Immune system, Allergy, Anaphylaxis, Epinephrine, Allergy test

According to the CDC's Voluntary Guidelines for Schools, the delay or failure to administer Epinephrine can contribute to fatal anaphylaxis cases from food allergies.

Key Points: 
  • According to the CDC's Voluntary Guidelines for Schools, the delay or failure to administer Epinephrine can contribute to fatal anaphylaxis cases from food allergies.
  • According to recent data, food allergy emergency room visits have also increased over 214% in the past couple of years.
  • Access to Epinephrine is a life-saver for those with food allergies, but storage and proximity to Epinephrine matter.
  • "After years of R&D leveraging the unique insights of our dedicated food allergy community, we're thrilled to achieve this granted patent status.

Ready, Set, Food Announces $3.5 Million Raised In Most Recent Funding Round, Fueled By New Investment From Edward-Elmhurst Health

Retrieved on: 
Thursday, June 3, 2021
Medical specialties, Immunology, Clinical medicine, Immune system disorders, Food allergies, Allergy, Immune system, Food, Peanut allergy

Developed by parents, for parents, following first-hand experiences with their kids' own childhood food allergies, the all-star team behind Ready, Set, Food!

Key Points: 
  • Developed by parents, for parents, following first-hand experiences with their kids' own childhood food allergies, the all-star team behind Ready, Set, Food!
  • With one in every twelve babies developing a food allergy each year, the investors' steadfast support ensures that Ready, Set, Food!
  • "I am proud to once again increase my investment from Shark Tank in Ready, Set, Food!
  • Founded by parents for parents, with a team of all-star physicians and leaders in allergy research, Ready, Set, Food!